QTTB Q32 Bio Inc.
$8.77
Q32 Bio Inc. (QTTB) Earnings News
Earnings press releases, previews and reviews for Q32 Bio Inc. (QTTB), newest first.
Monday
September 21, 2026
9:15 AM ET
Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Congress 2026
Monday
September 14, 2026
6:59 AM ET
Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
Wednesday
August 5, 2026
6:59 AM ET
Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Friday
July 10, 2026
4:05 PM ET
Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026
Tuesday
May 5, 2026
6:59 AM ET
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update